Skip to content

Author

Yan Yu

We have 1 of 19 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Aug 2026

Biomarker-driven neoadjuvant immunotherapy in triple-negative breast cancer: emerging therapeutic targets FOXP3 and WT1

This review delineates the principal neoadjuvant immunotherapy biomarkers implicated in breast cancer and elucidate their action mechanisms and summarizes the ongoing and reported clinical studies to offer a coherent perspective on the evolving role of neoadjuvant immunotherapy in breast cancer management.

Zi-Wei Zhang, Renjie Zhao, Yuan Hu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.